Summary
The effect of aspirin in vitro and in vivo on platelet aggregation has been studied in 13 diabetic subjects without retinopathy, 16 diabetic subjects with retinopathy and 20 ageand sex-matched control subjects. The rate, degree and duration of collagen-induced aggregation were greater in the diabetic patients (p < 0.05;p < 0.01;p < 0.05). The residual aggregation in vivo was greater in all diabetic patients with aspirin, whilst it only occurred in vitro in patients without retinopathy. A decreased latent period was seen in diabetic patients, to a greater extent in those with retinopathy. Significant differences in the rate, degree and duration of arachidonic acid-induced-aggregation were also seen in patients with retinopathy treated with aspirin (p < 0.05;p < 0.01;p < 0.05). Disaggregation only occurred with aspirin in vitro and was more frequently seen in normal subjects.
Article PDF
Similar content being viewed by others
References
Bensoussan D, Levy-Toledano S, Passa P, Caen J, Canivet J (1975) Platelet hyperaggregation and increased plasma level of vonWillebrand factor in diabetics and retinopathy. Diabetologia 11: 307–312
Born GVR (1962) Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature 194: 927–929
Charo IF, Feinman RD, Detwiler TC, Smith JB, Ingerman CM, Silver MJ (1977) Prostaglandin endoperoxides and thromboxane A2 can induce platelet aggregation in the absence of secretion. Nature 269: 66–69
Chignard M, Le Couedic JP, Varaftig BB, Benveniste J (1980) Platelet activating factor (PAF-acether) secretion from platelets: effect of aggregating agents. Br J Haematol 46: 455–464
Heath H, Brigden WD, Canever JV, Pollock J, Hunter PR, Kelsey J, Bloom A (1971) Platelet adhesiveness and aggregation in relation to diabetic retinopathy. Diabetologia 7: 308–315
Holmsen H (1965) Collagen induced release of adenosine diphosphate from blood platelets incubated with radioactive phosphate in vitro. Scand J Clin Lab Invest 17: 239–246
Khosla PK, Mahabaleshwara M, Tiwari HK, Saraya AK (1979) Platelet aggregation and retinal microangiopathy in diabetes and hypertension. Acta Haematol 61: 161–167
Kinlough-Rathbone RL, Packham MA, Mustard JF (1977) Synergism between platelet aggregating agents. The role of arachidonate pathway. Thrombosis Res 11: 567–580
Kwann HC, Colwell JA, Cruz S, Suwanwela N, Dobbie JG (1972) Increased platelet aggregation in diabetes mellitus. J Lab Clin Med 80: 236–246
Marcus AJ (1978) The role of lipids in platelet function with particular reference to the arachidonic acid pathway. J Lip Res 19: 793–826
Passa P, Bensoussan D, Levy-Toledano S, Caen J, Canivet J (1974) Study of platelet aggregation during diabetic retinopathy. Influence of hypophysectomy. Atherosclerosis 19: 277–285
Rome LH, Lands WEM, Roth GJ, Majerus PW (1976) Aspirin as a quantitative acetylating agent for the fatty acid oxygenase that forms prostaglandins. Prostaglandins 11: 23–30
Sagel J, Colwell JA, Crook L, Laimins M (1975) Increased platelet aggregation in early diabetes mellitus. Ann Int Med 82: 733–738
Samuelsson B (1977) The role of prostaglandin endoperoxides and thromboxanes as bioregulators. In: Kharasch N, Fried J (eds) Biochemical aspects of prostaglandins and thromboxanes. Proceedings Intra-science Symposium on New Biochemistry of prostaglandins and thromboxanes, Santa Monica, CA (1976). Academic Press, New York, pp 133–154
Silver MJ, Smith JB, Ingerman C, Kocsis JJ (1973) Arachidonic acid induced human platelet aggregation and prostaglandin formation. Prostaglandins 4: 863–875
Smith JB, Ingerman C, Kocsis JJ, Silver MJ (1974) Formation of an intermediate in prostaglandin biosynthesis and its association with the platelet release reaction. J Clin Invest 53: 1468–1472
Willis AL, Kuhn DC (1974) A new potential mediator of arterial thrombosis whose biosynthesis is inhibited by aspirin. Prostaglandins 4: 127–130
Willis AK, Vane FM, Kuhn DC, Scott CG, Petrin M (1974) An endoperoxide aggregator (LASS) Formed platelets in response to thrombotic stimuli: purification, identification and unique biological significance. Prostaglandins 8: 453–507
Zucker MB, Peterson J (1968) Inhibition of adenosine diphosphate induced secondary aggregation and other platelet functions by acetyl-salicylic acid ingestion. Proc Soc Exp Biol Med 127: 543–551
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Khosla, P.K., Seth, V., Tiwari, H.K. et al. Effect of aspirin on platelet aggregation in diabetes mellitus. Diabetologia 23, 104–107 (1982). https://doi.org/10.1007/BF01271169
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF01271169